For the quarter ending 2025-09-30, PLRX made $31,087K in revenue. -$26,266K in net income. Net profit margin of -84.49%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Research and development | 17,938 | 32,198 | 37,970 | 47,754 |
| General and administrative | 10,331 | 13,394 | 14,887 | 14,260 |
| Total operating expenses | 28,269 | 45,592 | 52,856 | 62,014 |
| Loss from operations | -28,269 | -45,592 | -52,856 | -62,014 |
| Interest and other income (expense), net | 2,783 | 3,101 | 5,152 | 5,128 |
| Interest expense | 815 | 809 | 640 | 877 |
| Net loss | -26,301 | -43,300 | -48,343 | -57,763 |
| Net unrealized gain (loss) on short-term investments | 35 | -160 | -680 | 1,465 |
| Total other comprehensive (loss) gain | - | - | -6 | - |
| Comprehensive loss | -26,266 | -43,460 | -49,024 | -56,298 |
| Net loss per share - basic (usd per share) | -0.43 | -0.71 | -0.8 | -0.95 |
| Net loss per share - diluted (usd per share) | -0.43 | -0.71 | -0.8 | -0.95 |
| Shares used in computing net loss per share - basic (in shares) | 61,406,475 | 61,386,183 | -30,287,546 | 60,730,935 |
| Shares used in computing net loss per share - diluted (in shares) | 61,406,475 | 61,386,183 | -30,287,546 | 60,730,935 |
PLIANT THERAPEUTICS, INC. (PLRX)
PLIANT THERAPEUTICS, INC. (PLRX)